![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Naidu P.S. Kulkarni S.K.
Publisher: Elsevier
ISSN: 0014-2999
Source: European Journal of Pharmacology, Vol.420, Iss.2, 2001-05, pp. : 113-117
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Higgins G.A. Kilpatrick G.J.
Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Advances in use of the 5-HT3 receptor antagonists
By Walton S.M.
Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 2, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Sam T.S.W. Cheng J.T.Y. Johnston K.D. Kan K.K.W. Ngan M.P. Rudd J.A. Wai M.K. Yeung J.H.K.
European Journal of Pharmacology, Vol. 472, Iss. 1, 2003-07 ,pp. :